Search Results 631-640 of 17840 for Coagulation
Coagulation parameters: International normalized ratio (INR) \>2, prolongation of prothrombin time (PT) and by \>1.5 x ULN at screening. 9. History of a ...
Have evidence of major coagulation disorders or other significant risks of hemorrhage such as: history of intracranial or intraspinal hemorrhage; tumor ...
Adequate coagulation function: International Normalized Ratio or INR must be <1.5 unless on therapeutic blood thinners). Bilirubin less than or equal to 1.5x ...
... coagulant medication within 30 days of Screening (Note: aspirin is permitted); severe degenerative arthritis of the lumbar spine; suspected non ...
Revisiting the effects of spectral interfering substances in optical end-point coagulation assays. Int J Lab Hematol. 2021 Oct; 43(5):1181-1190. Epub 2021 ...
... coagulant medications. Anti-platelet medications are not specifically exclusionary. Evidence of any clinically significant neurologic disease; Pregnancy or ...
Known clinically-significant (at the discretion of the investigator) laboratories in hematology, coagulation, clinical chemistry, or urinalysis, including, but ...
Clinically significant abnormal values at screening for hematology, clinical chemistry, coagulation or urinalysis. Abnormal arterial pressure at screening ...
This inherited blood vessel condition can cause bad nosebleeds, strokes, bleeding in the digestive tract and anemia.
About this study. The purpose of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.